Profile data is unavailable for this security.
About the company
Clover Biopharmaceuticals Ltd is an investment holding company primarily engaged in the research and development, manufacture and commercialization of innovative vaccines. The Company’s products and candidates include Respiratory Syncytial Virus (RSV) Vaccine (SCB-1019), seasonal quadrivalent influenza vaccine AdimFlu-S, SCB-219M, COVID-19 Vaccine and others. The Company leverages the Trimer-Tag technology platform to conduct research and development (R&D) for innovative vaccines that can fulfill unmet need, with a focus on building a respiratory vaccine franchise and establishing a presence in the pediatric vaccine market. The Trimer-Tag is a product development platform for the creation of protein-based vaccines based on naturally trimerization-dependent targets. The Company conducts its business in the domestic and overseas markets.
- Revenue in HKD (TTM)58.57m
- Net income in HKD-1.03bn
- Incorporated2018
- Employees243.00
- LocationClover Biopharmaceuticals LtdRoom 1901,No. 758 West Nanjing Road, Jing'an DistSHANGHAI ChinaCHN
- Websitehttps://www.cloverbiopharma.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HighTide Therapeutics Inc | 0.00 | -329.39m | 1.45bn | 57.00 | -- | 3.65 | -- | -- | -0.7286 | -0.7286 | 0.00 | 0.6934 | 0.00 | -- | -- | 0.00 | -49.50 | -- | -63.55 | -- | -- | -- | -- | -- | -- | -- | 0.2129 | -- | -- | -- | 59.35 | -- | -- | -- |
| Immunotech Biopharm Ltd | 0.00 | -252.85m | 1.57bn | 173.00 | -- | -- | -- | -- | -0.4518 | -0.4518 | 0.00 | -0.2878 | 0.00 | -- | -- | 0.00 | -37.04 | -36.20 | -186.73 | -45.67 | -- | -- | -- | -- | 0.0712 | -6.63 | 1.48 | -- | -- | -- | 44.18 | -- | 5.95 | -- |
| Cloudbreak Pharma Inc | 78.15m | -326.93m | 1.92bn | 60.00 | -- | -- | -- | 24.58 | -0.3897 | -0.3897 | 0.0932 | -3.08 | -- | -- | -- | 1,532,373.00 | -- | -- | -- | -- | -- | -- | -418.33 | -- | -- | -- | 19.44 | -- | -- | -- | 23.40 | -- | -- | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | 126.82m | -342.43m | 1.96bn | 195.00 | -- | 3.06 | -- | 15.48 | -0.8705 | -0.8705 | 0.3221 | 1.48 | 0.148 | -- | 3,865.48 | 812,941.60 | -40.09 | -- | -51.56 | -- | -- | -- | -270.79 | -- | -- | -- | 0.2236 | -- | 19,109.59 | -- | 16.76 | -- | -- | -- |
| Mabpharm Ltd | 479.59m | -31.09m | 2.10bn | 383.00 | -- | 18.81 | 57.03 | 4.39 | -0.0076 | -0.0076 | 0.1163 | 0.0271 | 0.4209 | 0.4659 | 4.05 | 1,522,523.00 | -2.73 | -19.62 | -4.02 | -25.69 | 86.40 | -- | -6.48 | -211.59 | 0.6906 | -1.58 | 0.7552 | -- | 196.27 | -- | 38.89 | -- | -12.13 | -- |
| Jiangsu Recbio Technology Co Ltd | 12.33m | -739.77m | 2.17bn | 507.00 | -- | 10.61 | -- | 176.26 | -1.55 | -1.55 | 0.0258 | 0.4242 | 0.006 | -- | -- | 23,220.65 | -36.26 | -31.31 | -64.03 | -37.31 | -- | -- | -5,990.59 | -- | 0.2767 | -100.74 | 0.8254 | -- | -- | -- | 1.67 | -- | 16.82 | -- |
| Frontage Holdings Corp | 1.98bn | 29.97m | 2.20bn | 1.54k | 73.12 | 0.8238 | 6.99 | 1.11 | 0.0148 | 0.0148 | 0.9735 | 1.31 | 0.4545 | 60.36 | 3.97 | 1,267,499.00 | 0.6902 | 3.05 | 0.8654 | 3.64 | 27.78 | 32.14 | 1.52 | 6.84 | 1.22 | 1.97 | 0.2861 | 0.00 | -1.90 | 20.48 | -92.68 | -46.72 | 13.29 | -- |
| Antengene Corp Ltd | 95.43m | -258.61m | 2.34bn | 152.00 | -- | 2.70 | -- | 24.56 | -0.4162 | -0.4162 | 0.1536 | 1.28 | 0.0619 | 1.51 | 3.20 | 564,671.80 | -16.77 | -48.14 | -19.52 | -53.06 | 78.54 | -- | -271.00 | -1,460.93 | 4.41 | -- | 0.2346 | -- | 36.62 | -- | 45.07 | -- | 259.46 | -- |
| Hanx Biopharmaceuticals (Wuhan) Co Ltd | -100.00bn | -100.00bn | 2.62bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -52.30 | -- | -- | -- |
| Clover Biopharmaceuticals Ltd | 58.57m | -1.03bn | 2.86bn | 243.00 | -- | -- | -- | 48.76 | -0.8194 | -0.8194 | 0.0466 | -1.49 | 0.0433 | 0.0547 | 47.89 | 195,238.00 | -76.07 | -75.37 | -- | -188.14 | 62.57 | -- | -1,756.85 | -13,419.00 | 0.2541 | -- | -- | -- | -2.13 | -- | -552.11 | -- | -24.90 | -- |
| BioDlink International Co Ltd | 1.21bn | 8.21m | 3.25bn | 604.00 | 370.88 | 3.92 | 35.55 | 2.69 | 0.0113 | 0.0113 | 1.66 | 1.07 | 0.7275 | 2.35 | 5.49 | 1,975,381.00 | 0.495 | -11.37 | 0.6586 | -14.89 | 71.10 | 73.14 | 0.6805 | -24.91 | 1.68 | 1.83 | 0.3519 | -- | 40.70 | 89.20 | 192.05 | -- | 27.04 | -- |
| Hua Medicine | 419.33m | 1.22bn | 3.30bn | 285.00 | 2.55 | 2.56 | 2.62 | 7.86 | 1.23 | 1.23 | 0.4248 | 1.22 | 0.2411 | 1.76 | 5.71 | 2,496,030.00 | 69.99 | -21.83 | 82.64 | -25.31 | 52.55 | -- | 290.30 | -395.24 | 7.00 | -- | 0.2038 | -- | 234.02 | -- | -18.42 | -- | -17.81 | -- |
| Medtide Inc | -100.00bn | -100.00bn | 3.61bn | 520.00 | -- | 2.17 | -- | -- | -- | -- | -- | 11.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 4.48 | -- | 0.0335 | -- | 31.31 | -- | 21.00 | -- | -- | -- |
| Visen Pharmaceuticals | -100.00bn | -100.00bn | 3.88bn | 54.00 | -- | 3.70 | -- | -- | -- | -- | -- | 9.22 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0014 | -- | -- | -- | 26.98 | -- | -- | -- |
Data as of Feb 16 2026. Currency figures normalised to Clover Biopharmaceuticals Ltd's reporting currency: Hong Kong Dollar HKD
0.36%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 31 Dec 2025 | 4.57m | 0.35% |
| Fidelity Investments Canada ULCas of 30 Nov 2025 | 151.53k | 0.01% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 5.00k | 0.00% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
